April W Armstrong

104PUBLICATIONS
258CO-AUTHORS
Clinical pharmacology and therapeuticsCardiology (incl. cardiovascular diseases)Clinical social work practiceToxicology (incl. clinical toxicology)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (104)

|Aug 06, 2026
Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5-Year Analysis of the Phase 3 POETYK PSO-1, PSO-4, and Long-Term Extension Trials.

|Jul 09, 2026
A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score.

|Jul 01, 2026
GRAPPA 2025 Annual Meeting Report: Session on Geographic Variations in Psoriatic Arthritis/Psoriasis Care and Resource Limitations.

|May 16, 2026
Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.

|Apr 14, 2026
Treatment Patterns in Pediatric Hidradenitis Suppurativa: Time to Treatment Initiation, Initial Treatment, and Time to Switching.

Shaliz Aflatooni, Andrea Ure, Kimberly Smart

|Apr 04, 2026
Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review.

April W Armstrong, James G Krueger, Bruce E Strober

Pageof 18

Frequent Collaborators

13 joint publications

Joseph F Merola

10 joint publications

Alice B Gottlieb

10 joint publications

Alexis Ogdie

9 joint publications

Philip Mease